Determiner of Poor Sleep Quality in Chronic Kidney Disease Patients Links to Elevated Diastolic Blood Pressure, hs-CRP, and Blood-count-based Inflammatory Predictors

Maulana Antiyan Empitu, Ika Nindya Kadariswantiningsih, Mochammad Thaha, Cahyo Wibisono Nugroho, Eka Arum Cahyaning Putri, Zaky El Hakim, Maulana Muhtadin Suryansyah, Rieza Rizqi Alda, Mohammad Yusuf Alsagaff, Mochammad Amin, Djoko Santoso, Yusuke Suzuki


BACKGROUND: Sleep deprivation is strongly associated with cardiovascular disease (CVD) via sympathetic overstimulation and systemic inflammation in general population. However, the significance of poor sleep quality in chronic kidney disease (CKD) is still underexplored.

METHODS: This study assessed the sleep quality of 39 with non-dialysis CKD (ND CKD) patients and 25 hemodialysis CKD (HD CKD) patients using the Pittsburgh Sleep Quality Index (PSQI) questionnaire. Poor sleeper was defined as individual with PSQI > 5.

RESULTS: The prevalence of poor sleeper (30% vs. 60%, p=0.029) and the cummulative PSQI (ND CKD 4.5±4.4, HD CKD 8±6, p=0.038) are different between ND CKD and HD CKD groups. Among the ND CKD, there are association between short sleep duration (< 5 hours per day) with elevated diastolic blood pressure groups (r=0.421, p<0.05); habitual sleep efficiency with platelet-to-lymphocyte ratio (r= 0.532, p<0.0001); daytime dysfunction with increased hs-CRP (r=0.345, p=0.032) and neutrophil-to-lymphocyte ratio (r=0.320, p=0.046). In HD CKD group, a requirement to use sleep medication was associated with elevated highsensitivity C-reactive protein (hs-CRP) level (r=0.434, p=0.030) and decreased monocyte-to-lymphocyte ratio (r=- 0.410, p=0.042); daytime dysfunction was associated with serum hs-CRP (r=0.452, p=0.023).

CONCLUSION: This study revealed that some features of poor sleep quality in CKD patients including low sleep efficiency, daytime dysfunction and requirement to use sleep medication were associated with increased diastolic blood pressure, hs-CRP and blood-count-based inflammatory predictors. Thus, this finding prompt to pay closer attention to sleep complaints in the management of CVD risk factors in CKD patients.

KEYWORDS: sleep quality, chronic kidney disease, blood pressure, inflammation

Full Text:



Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017; 390: 1888-917, CrossRef.

Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013; 382: 260-72, CrossRef.

Empitu MA, Kadariswantiningsih IN, Aizawa M, Asanuma K. MAGI-2 and scaffold proteins in glomerulopathy. Am J Physiol Physiol. 2018; 315: F1336-44, CrossRef.

Thaha M, Yusuf M, Empitu MA, Bakarman A, Tomino Y. Distribution of dimethylarginine-dimethylaminohydrolase-II (DDAH2) gene polymorphism in hemodialysis patients. Acta Med Indones. 2013; 45: 83-8, article.

Kasiske BL, Wheeler DC. KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease: Foreword. Kidney Int Suppl. 2013; 3(1): 2, CrossRef.

Turek NF, Ricardo AC, Lash JP. Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence. Am J Kidney Dis. 2012; 60: 823-33, CrossRef.

Spiegel K, Leproult R, L’Hermite-Balériaux M, Copinschi G, Penev PD, Van Cauter E. Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab. 2004; 89: 5762–71, CrossRef.

Murck H, Uhr M, Ziegenbein M, Künzel H, Held K, Antonijevic IA, et al. Renin-angiotensin-aldosterone system, HPA-axis and sleepEEG changes in unmedicated patients with depression after total sleep deprivation. Pharmacopsychiatry. 2006; 39: 23-9, CrossRef.

Patel SR, Zhu X, Storfer-Isser A, Mehra R, Jenny NS, Tracy R, et al. Sleep duration and biomarkers of inflammation. Sleep. 2009; 32: 200-4, CrossRef.

Xu G, Luo K, Liu H, Huang T, Fang X, Tu W. The progress of inflammation and oxidative stress in patients with chronic kidney disease. Renal Failure. 2015; 37: 45-9, CrossRef.

Malhotra R, Marcelli D, von Gersdorff G, Grassmann A, Schaller M, Bayh I, et al. Relationship of neutrophil-to-lymphocyte ratio and serum albumin levels with C-reactive protein in hemodialysis patients: results from 2 international cohort studies. Nephron. 2015; 130: 263-70, CrossRef.

Buysse DJ, Reynolds III CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28: 193-213, CrossRef.

Thaha M, Empitu MA, Kadariswantiningsih IN, Nugroho CW, Hasanatuludhhiyah N, Rasyid H, et al. Anthropometry-based body fat percentage predicts high hs-CRP in chronic kidney disease patients. Indones Biomed J. 2018; 10: 184-91, CrossRef.

Wolk R, Somers VK. Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes, Obes Metab. 2006; 8: 250-60, CrossRef.

Merlino G, Piani A, Dolso P, Adorati M, Cancelli I, Valente M, et al. Sleep disorders in patients with end-stage renal disease undergoing dialysis therapy. Nephrol Dial Transplant. 2005; 21: 184-90, CrossRef.

Nishiyama T, Mizuno T, Kojima M, Suzuki S, Kitajima T, Ando KB, et al. Criterion validity of the Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale for the diagnosis of sleep disorders. Sleep Med. 2014; 15: 422-9, CrossRef.

Knutson KL, Van Cauter E, Rathouz PJ, Yan LL, Hulley SB, Liu K, et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch Intern Med. 2009; 169: 1055-61, CrossRef.

Brandenberger G, Ehrhart J, Piquard F, Simon C. Inverse coupling between ultradian oscillations in delta wave activity and heart rate variability during sleep. Clin Neurophysiol. 2001; 112: 992-6, CrossRef.

Roumelioti M-E, Ranpuria R, Hall M, Hotchkiss JR, Chan CT, Unruh ML, et al. Abnormal nocturnal heart rate variability response among chronic kidney disease and dialysis patients during wakefulness and sleep. Nephrol Dial Transplant. 2010; 25: 3733-41, CrossRef.

Turkmen K, Erdur FM, Ozcicek F, Ozcicek A, Akbas EM, Ozbicer A, et al. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013; 17: 391-6, CrossRef.

Imeri L, Opp MR. How (and why) the immune system makes us sleep. Nat Rev Neurosci. 2009; 10: 199-210, CrossRef.

Opp MR. Cytokines and sleep. Sleep Med Rev. 2005; 9: 355-64, CrossRef.

Krueger JM. The role of cytokines in sleep regulation. Curr Pharm Des. 2008; 14: 3408-16, CrossRef.

Stenvinkel P, Gillespie IA, Tunks J, Addison J, Kronenberg F, Drueke TB, et al. Inflammation modifies the paradoxical association between body mass index and mortality in hemodialysis patients. J Am Soc Nephrol. 2016; 27: 1479-86, CrossRef.

Zhang J, Wang C, Gong W, Peng H, Tang Y, Li CC, et al. Association between sleep quality and cardiovascular damage in pre-dialysis patients with chronic kidney disease. BMC Nephrol. 2014; 15: 131, CrossRef.

Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. Jama. 2003; 289: 76-9, CrossRef.

Plantinga L, Lee K, Inker LA, Saran R, Yee J, Gillespie B, et al. Association of sleep-related problems with CKD in the United States, 2005-2008. Am J Kidney Dis. 2011; 58: 554-64, CrossRef.

Santo De RM, Bartiromo M, Cesare CM, Cirillo M. Sleep disorders occur very early in chronic kidney disease. J Nephrol. 2008; 21: S59-65, PMID.


Copyright (c) 2019 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Indexed by:






The Prodia Education and Research Institute